REGENCELL BIOSCIENCE HOLDING (RGC) Stock Price & Overview

NASDAQ:RGC • KYG7487R1002

Current stock price

25.67 USD
+0.27 (+1.06%)
At close:
25.5 USD
-0.17 (-0.66%)
After Hours:

The current stock price of RGC is 25.67 USD. Today RGC is up by 1.06%. In the past month the price decreased by -2.13%. In the past year, price increased by 3700%.

RGC Key Statistics

52-Week Range0.552634 - 83.6
Current RGC stock price positioned within its 52-week range.
1-Month Range20 - 29.5
Current RGC stock price positioned within its 1-month range.
Market Cap
12.694B
P/E
N/A
Fwd P/E
N/A
EPS (TTM)
N/A
Dividend Yield
N/A

RGC Stock Performance

Today
+1.06%
1 Week
-6.21%
1 Month
-2.13%
3 Months
+21.31%
Longer-term
6 Months +70.00%
1 Year +3,700.00%
2 Years +21,576.90%
3 Years +3,669.16%
5 Years N/A
10 Years N/A

RGC Stock Chart

REGENCELL BIOSCIENCE HOLDING / RGC Daily stock chart

RGC Technical Analysis

ChartMill assigns a technical rating of 6 / 10 to RGC. When comparing the yearly performance of all stocks, RGC is one of the better performing stocks in the market, outperforming 99.97% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

RGC Fundamental Analysis

ChartMill assigns a fundamental rating of 2 / 10 to RGC. No worries on liquidiy or solvency for RGC as it has an excellent financial health rating, but there are worries on the profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

RGC Earnings

Next Earnings DateN/A
Last Earnings DateOct 23, 2025
PeriodQ2 / 2025
EPS Reported
Revenue Reported
EPS Surprise %
Revenue Surprise %

RGC Forecast & Estimates


Analysts
Analysts63.4
Price TargetN/A
EPS Next YN/A
Revenue Next YearN/A

RGC Groups

Sector & Classification

Sub-Industry
Pharmaceuticals
Index Membership

RGC Financial Highlights


Income Statements
Revenue(TTM)N/A
Net Income(TTM)-4.09M
Industry RankSector Rank
PM (TTM) N/A
ROA -54.68%
ROE -60.86%
Debt/Equity 0
Chartmill High Growth Momentum
EPS Q2Q%N/A
Sales Q2Q%N/A
EPS 1Y (TTM)100%
Revenue 1Y (TTM)N/A

RGC Ownership

Ownership
Inst Owners0.11%
Shares494.49M
Float56.59M
Ins Owners88.56%
Short Float %1.12%
Short Ratio1.35

About RGC

Company Profile

RGC logo image Regencell Bioscience Holdings Ltd. is a early-stage bioscience company that focuses on research, development and commercialization of Traditional Chinese Medicine for the treatment of neurocognitive disorders and degeneration, specifically Attention Deficit Hyperactivity Disorder and Autism Spectrum Disorder. The company employs 12 full-time employees The company went IPO on 2021-07-16. The firm launches three liquid based standardized TCM formulae candidates for mild, moderate and severe ADHD and ASD patients.

Company Info

IPO: 2021-07-16

REGENCELL BIOSCIENCE HOLDING

11/F, First Commercial Building, 33-35 Leighton Road, Causeway Bay

Hong Kong 37918 HK

CEO: Yat-Gai Au

Employees: 12

RGC Company Website

RGC Investor Relations

Phone: 85221550823

REGENCELL BIOSCIENCE HOLDING / RGC FAQ

What does RGC do?

Regencell Bioscience Holdings Ltd. is a early-stage bioscience company that focuses on research, development and commercialization of Traditional Chinese Medicine for the treatment of neurocognitive disorders and degeneration, specifically Attention Deficit Hyperactivity Disorder and Autism Spectrum Disorder. The company employs 12 full-time employees The company went IPO on 2021-07-16. The firm launches three liquid based standardized TCM formulae candidates for mild, moderate and severe ADHD and ASD patients.


What is the current price of RGC stock?

The current stock price of RGC is 25.67 USD. The price increased by 1.06% in the last trading session.


Does RGC stock pay dividends?

RGC does not pay a dividend.


What is the ChartMill rating of REGENCELL BIOSCIENCE HOLDING stock?

RGC has a ChartMill Technical rating of 6 out of 10 and a ChartMill Fundamental rating of 2 out of 10.


Which stock exchange lists RGC stock?

RGC stock is listed on the Nasdaq exchange.


Can you provide the sector and industry classification for REGENCELL BIOSCIENCE HOLDING?

REGENCELL BIOSCIENCE HOLDING (RGC) operates in the Health Care sector and the Pharmaceuticals industry.